Initial solid tumor testing (Stage 1) of AZD1480, an inhibitor of Janus kinases 1 and 2 by the pediatric preclinical testing program期刊界 All Journals 搜尽天下杂志传播学术成果专业期刊搜索期刊信息化学术搜索

Initial solid tumor testing (Stage 1) of AZD1480, an inhibitor of Janus kinases 1 and 2 by the pediatric preclinical testing program

Authors:	Peter J. Houghton PhD Raushan T. Kurmasheva PhD Dmitry Lyalin PhD John M. Maris MD E. Anders Kolb MD Richard Gorlick MD C. Patrick Reynolds MD PhD Min H. Kang PharmD Stephen T. Keir PhD Jianrong Wu PhD Malcolm A. Smith MD PhD

Affiliation:	1. Nationwide Children's Hospital, , Columbus, Ohio;2. Children's Hospital of Philadelphia, University of Pennsylvania School of Medicine and Abramson Family Cancer Research Institute, , Philadelphia, Pennsylvania;3. A.I. duPont Hospital for Children, , Wilmington, Delaware;4. The Children's Hospital at Montefiore, , Bronx, New York;5. Texas Tech University Health Sciences Center, , Lubbock, Texas;6. Duke University Medical Center, , Durham, North Carolina;7. St. Jude Children's Research Hospital, , Memphis, Tennessee;8. Cancer Therapy Evaluation Program, NCI, , Bethesda, Maryland

Abstract:

Keywords:	developmental therapeutics JAK1/2 inhibitor preclinical testing